Concepedia
Statistics
Publications
3
Citations
83
H-Index
Active since
2022
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (Finland)
AstraZeneca (Australia)
AstraZeneca (Germany)
University of Gothenburg
Dmitrii Degtev is an author at AstraZeneca (Sweden) specializing in genetics, crispr-cas systems, and molecular biology.
Publications per year
2022–2024
Harnessing DSB repair to promote efficient homology-dependent and -independent prime editing
Martin Peterka, Nina Akrap, Songyuan Li et al. · Nature Communications · 2022 · 51 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo
Burcu Bestas, Sandra Wimberger, Dmitrii Degtev et al. · Nature Communications · 2023 · 19 citations · Full text
Life Sciences, Genetics, Molecular Biology +15
Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
Dmitrii Degtev, Jack P. K. Bravo, Aikaterini Emmanouilidi et al. · Nature Communications · 2024 · 13 citations · Full text
Life Sciences, Biotechnology, Molecular Biology +16
1–3 of 3